almagate has been researched along with Glaucoma, Open-Angle in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoguet, A; Parrish, RK | 1 |
| Frenkel, MP; Frenkel, RE; Mani, L; Toler, AR | 1 |
| Feucht, N; Kotliar, KE; Lanzl, IM; Lohmann, CP; Maier, M | 1 |
3 other study(ies) available for almagate and Glaucoma, Open-Angle
| Article | Year |
|---|---|
Unexpected hypotony after glaucoma drainage implant surgery associated with anti-vascular endothelial growth factor treatment.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Female; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Intravitreal Injections; Ocular Hypotension; Postoperative Complications; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2015 |
Intraocular pressure effects of pegaptanib (Macugen) injections in patients with and without glaucoma.
Topics: Aged; Antihypertensive Agents; Aptamers, Nucleotide; Chronic Disease; Glaucoma, Open-Angle; Humans; Injections; Intraocular Pressure; Macular Degeneration; Retrospective Studies; Time Factors; Tonometry, Ocular; Vascular Endothelial Growth Factor A; Vitreous Body | 2007 |
Intraocular pressure effects of pegaptanib (macugen) injections in patients with and without glaucoma.
Topics: Angiogenesis Inhibitors; Aptamers, Nucleotide; Chronic Disease; Glaucoma, Open-Angle; Humans; Injections; Intraocular Pressure; Macular Degeneration; Tonometry, Ocular; Vascular Endothelial Growth Factor A; Vitreous Body | 2008 |